Patents by Inventor Toshihiro Akaike

Toshihiro Akaike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200140892
    Abstract: The present invention is a cell transfer agent comprising a composite particle coated by a sugar chain polymer wherein the composite particle consisting of an apatite comprising phosphate, carbonic acid, and calcium.
    Type: Application
    Filed: May 29, 2017
    Publication date: May 7, 2020
    Inventors: Toshihiro AKAIKE, Mitsuaki GOTO
  • Publication number: 20200038483
    Abstract: A material for treatment of brain injury, a method for treatment of brain injury, a material for regeneration of brain neurons, and a method for regeneration of brain neurons are provided. The material for treatment of brain injury contains a carrier on which at least one selected from the group consisting of N-cadherin, a fusion protein containing an entire or partial region of N-cadherin, and a fusion protein containing an entire or partial region of a protein having homology to N-cadherin is immobilized or coated.
    Type: Application
    Filed: June 28, 2019
    Publication date: February 6, 2020
    Applicants: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, SOMAR CORPORATION
    Inventors: Kazunobu SAWAMOTO, Hideo JINNOU, Masato SAWADA, Itsuki AJIOKA, Toshihiro AKAIKE
  • Patent number: 9745549
    Abstract: [Problem] To provide a cell culture substrate, and a cell culturing method using the substrate and a method for inducing differentiation of pluripotent stem cells using the substrate, which allow culturing of pluripotent stem cells and allow differentiation of pluripotent stem cells into a specified cell species, particularly neural and neural progenitor cells, at a high purity. [Means for Solution] A cell culture substrate, characterized in that, onto the surface, one or more selected from the group consisting of N-cadherin, a fusion protein comprising an entire or partial region of N-cadherin, and a fusion protein comprising an entire or partial region of a protein homologous to N-cadherin are immobilized or coated.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: August 29, 2017
    Assignees: SOMAR CORP.
    Inventors: Amranul Haque, Masato Nagaoka, Toshihiro Akaike
  • Patent number: 9617543
    Abstract: A sugar chain-containing polymer that enables targeting to the lesion area of liver fibrosis and is useful for imaging, diagnosis and therapy of liver fibrosis; and a sugar chain-containing polymer complex comprising the polymer as a carrier for an anionic substance useful fix therapy and the like; are provided. The polymer is a sugar chain-containing polymer which is a cationic polymer comprising an amine, which polymer comprises N-acetylglucosamine bound thereto. The polymer preferably has a disulfide bond. The polymer preferably has a structure in which polyethyleneimine is linked via a disulfide bond.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: April 11, 2017
    Assignees: SOMAR CORP., KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Bong Hyun Chung, Hirohiko Ise, Toshihiro Akaike, Sun-Jung Kim
  • Patent number: 9295640
    Abstract: A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: March 29, 2016
    Assignees: IJUNKAI
    Inventors: Hirofumi Yamamoto, Hiroyuki Nakanishi, Toshihiro Akaike, Masaki Mori, Yuichiro Doki, Xin Wu
  • Publication number: 20150148527
    Abstract: A sugar chain-containing polymer that enables targeting to the lesion area of liver fibrosis and is useful for imaging, diagnosis and therapy of liver fibrosis; and a sugar chain-containing polymer complex comprising the polymer as a carrier for an anionic substance useful fix therapy and the like; are provided. The polymer is a sugar chain-containing polymer which is a cationic polymer comprising an amine, which polymer comprises N-acetylglucosamine bound thereto. The polymer preferably has a disulfide bond. The polymer preferably has a structure in which polyethyleneimine is linked via a disulfide bond.
    Type: Application
    Filed: May 27, 2014
    Publication date: May 28, 2015
    Applicants: SOMAR Corp., KOREAN RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Bong Hyun CHUNG, Hirohiko ISE, Toshihiro AKAIKE, Sun-Jung KIM
  • Publication number: 20140302145
    Abstract: A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed.
    Type: Application
    Filed: August 27, 2013
    Publication date: October 9, 2014
    Inventors: Toshihiro Akaike, Masaki Mori, Yuichiro Doki, Hirofumi Yamamoto, Hiroyuki Nakanishi
  • Publication number: 20140113372
    Abstract: [Problem] To provide a cell culture substrate, and a cell culturing method using the substrate and a method for inducing differentiation of pluripotent stem cells using the substrate, which allow culturing of pluripotent stem cells and allow differentiation of pluripotent stem cells into a specified cell species, particularly neural and neural progenitor cells, at a high purity. [Means for Solution] A cell culture substrate, characterized in that, onto the surface, one or more selected from the group consisting of N-cadherin, a fusion protein comprising an entire or partial region of N-cadherin, and a fusion protein comprising an entire or partial region of a protein homologous to N-cadherin are immobilized or coated.
    Type: Application
    Filed: April 18, 2013
    Publication date: April 24, 2014
    Applicants: SOMAR Corp.
    Inventors: Somar Corp., Toshihiro Akaike
  • Patent number: 7892835
    Abstract: A novel growing method is provided for pluripotent stem cells such as ES cells. The method of the invention is a pluripotent stem cell growing method and gene transfer method in which pluripotent stem cells are cultured under conditions that maintain their undifferentiated state and pluripotency, the method being characterized by using a liquid medium and a culturing vessel having immobilized or coated on a substrate solid phase surface a molecule which is adhesive to the pluripotent stem cells in a fixed concentration, to grow the pluripotent stem cells in a dispersed state while maintaining their undifferentiated state and pluripotency, without using feeder cells, or to transfer and express a gene therein.
    Type: Grant
    Filed: March 23, 2005
    Date of Patent: February 22, 2011
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Toshihiro Akaike, Keiichi Fukuda, Masato Nagaoka, Uichi Koshimizu
  • Publication number: 20070155013
    Abstract: A novel growing method is provided for pluripotent stem cells such as ES cells. The method of the invention is a pluripotent stem cell growing method and gene transfer method in which pluripotent stem cells are cultured under conditions that maintain their undifferentiated state and pluripotency, the method being characterized by using a liquid medium and a culturing vessel having immobilized or coated on a substrate solid phase surface a molecule which is adhesive to the pluripotent stem cells in a fixed concentration, to grow the pluripotent stem cells in a dispersed state while maintaining their undifferentiated state and pluripotency, without using feeder cells, or to transfer and express a gene therein.
    Type: Application
    Filed: March 23, 2005
    Publication date: July 5, 2007
    Applicants: Toshihiro Akaike, Keiichi Fukuda, Daiichi Asubio Pharma Co., Ltd.
    Inventors: Toshihiro Akaike, Keiichi Fukuda, Masato Nagaoka, Uichi Koshimizu
  • Publication number: 20070077306
    Abstract: When a solution of an inorganic phosphoric acid, added to with calcium ions and magnesium ions, is incubated for a preset time duration, an apatite particle obtained is reduced in size, depending on the concentration of the magnesium ions. By employing an apatite particle, for which the concentration of the magnesium ions and the incubation time duration are controlled adequately, it is possible to improve the gene transfection efficiency into the cells and the gene expression efficiency in the cells.
    Type: Application
    Filed: December 27, 2004
    Publication date: April 5, 2007
    Inventors: Toshihiro Akaike, Ezharul Chowdhury
  • Patent number: 6642050
    Abstract: A cell culture material comprising a sugar containing polymer in which at least one kind of sugar chain is bonded as a side chain via a spacer molecule is made into a three-dimensional shape whereupon a three-dimensional cell material is prepared. With regard to the sugar containing polymer, a sugar containing polymer having a carboxyl group such as alginic acid, hyaluronic acid, pectic acid or a derivative thereof is preferably used. Sugar chain having a specific recognition to a cell is bonded as a side chain and, therefore, when the cell is incubated using the cell culture material, it is possible to maintain and improve the proliferation, morphology and function of the cells and to retain the cell form in a form of near that in vivo due to a specific interaction between the cell and the sugar chain.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: November 4, 2003
    Assignee: Amcite Research, Ltd.
    Inventors: Mitsuaki Goto, Toshihiro Akaike, Jun Yang
  • Patent number: 6372194
    Abstract: This relates to a contrast medium containing a complex of a gadolinium (Gd) type contrast agent and a polymer. More particularly, the contrast medium wherein the polymer capable of phase transit in response to environmental changes, particularly, pH, light or temperature, to develop a different water solubility, and a method for imaging by the use of this contrast medium. By binding a polymer responsive to microenvironmental changes with a Gd type MRI contrast agent, on-off switching of MRI imaging capability is enabled, wherein imaging occurs only on the target sites. Consequently, a highly specific MRI contrast medium can be obtained, whereby a highly specific MRI diagnosis is made possible, wherein only the target sites such as a tumor and a particular site are imaged and otherwise at the site where imaging is not necessary.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: April 16, 2002
    Assignees: Nihon Schering K.K.
    Inventors: Toshihiro Akaike, Masahito Mikawa, Atsushi Maruyama, Naoto Miwa
  • Publication number: 20020016304
    Abstract: A carrier for stabilizing a nucleic acid is provided which forms a soluble, stable complex with a nucleic acid, which has a stabilizing effect on a double or triple helix of a nucleic acid, which suppresses the structural change of a nucleic acid, and which enables the reversibility of a nucleic acid to be retained. A method for stabilizing a nucleic acid by use of such a carrier is also provided. This carrier is a polymer having a poly(cationic amino acid) as a main chain, and a comb-shaped hydrophilic group as a side chain modifying the polymer.
    Type: Application
    Filed: March 15, 1999
    Publication date: February 7, 2002
    Inventors: ATSUSHI MARUYAMA, TOSHIHIRO AKAIKE, TAKESHI GOTO, KEISHI YONEMURA
  • Patent number: 6150461
    Abstract: A carrier for delivering a foreign substance to a target organ which comprises a graft copolymer in which hyaluronic acid is grafted on a polymer composing main chain, wherein the main chain has a part capable of binding to the foreign substance electrostatically, and contains one or more monomer unit having side chain with amino or imino group capable of coupling to hyarulonic acid, which is useful for delivering a foreign substance to a target organ, especially liver.
    Type: Grant
    Filed: May 27, 1997
    Date of Patent: November 21, 2000
    Assignees: Hisamitsu Pharmaceutical Co., Inc., Rohto Pharmaceutical Co., Ltd.
    Inventors: Yoshiyuki Takei, Atsushi Maruyama, Toshihiro Akaike, Sunao Kawano, Shigetoshi Okumura, Masayuki Nogawa, Shoichiro Asayama
  • Patent number: 5679559
    Abstract: A composition for delivery of a selected nucleic acid into a targeted host cell comprises a complex of a hydrophobized, positively charged, biocompatible polymer; a lipoprotein; and a selected nucleic acid. Hydrophobic and electrostatic interactions between the components provide for the formation of the condensed DNA-containing complex. Preferred embodiments of the complex have a slightly positive surface charge and an average diameter of about 200 nm. Plasmids and oligonucleotides can be efficiently delivered with such compositions. A method of delivering a selected nucleic acid to a host cell is also disclosed.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: October 21, 1997
    Assignee: University of Utah Research Foundation
    Inventors: Jin-Seok Kim, Atsushi Maruyama, Toshihiro Akaike, Sung Wan Kim
  • Patent number: 5470739
    Abstract: The invention discloses a cell culture support which provides for the adhesion and culturing of one or more adhesive cells using a photoresist in which to provide a particular patterned design on a surface of the support. The patterned design is provided by the photoresist which is partially removed by photolithography during the making of the support which in turn imparts a striped, checkerboard or dotted pattern on the surface of the support. Further, the cell culture support is produced by pretreating the support surface with a reagent to provide hydrophobicity to the support surface. Also a reagent can be added to pretreat the support surface in order to facilitate adhesion at the photoresist prior to applying the photoresist into the cell culture support. Collagen is applied in the form of a solution, containing in addition thereto albumin and a crosslinking agent, in order to form a film. Collagen specifically affects the cell adhesion rate or the morphology of the cells to be adhered to the support.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: November 28, 1995
    Assignee: NEC Corporation
    Inventors: Toshihiro Akaike, Seishiro Tobe, Shigeyuki Miyamoto, Akio Ohashi
  • Patent number: 5206318
    Abstract: A styrene derivative carrying N-acethylchito-oligosaccharide chains, a polystyrene derivative carrying N-acetylchito-oligosaccharide chains on the side chains as well as a method for preparing these compounds are herein disclosed. The method for preparing the styrene derivative comprises reacting N-acetylchito-oligosaccharide lactone with vinylbenzylamine or a derivative thereof while the method for preparing the polystyrene derivative comprises polymerizing the styrene derivative. These derivatives can be employed as biomedical materials, in particular as materials for cell culture.
    Type: Grant
    Filed: March 20, 1992
    Date of Patent: April 27, 1993
    Assignee: Mitsui Toatsu Chemicals, Inc.
    Inventors: Kazukiyo Kobayashi, Toshihiro Akaike, Hosei Shinoda, Kazushi Morimoto
  • Patent number: 5124437
    Abstract: A galactosamine substituted poly-.omega.-alkyl (or benzyl)-L-glutamic acid (or aspartic acid) is provided and comprises a polypeptide having the recurring unit represented by the formula: ##STR1## wherein X has a value of 60 to 250; n is 1 or 2; and R represents a lower alkyl group or benzyl group, in which a part or all of the peptide in said polypeptide is substituted by an .omega.-galactosamyl-L-glutamic acid (or aspartic acid) residue represented by the general formula: ##STR2## wherein n is as indicated.
    Type: Grant
    Filed: April 23, 1991
    Date of Patent: June 23, 1992
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Toshihiro Akaike, Ichirou Kitada, Megumi Kunou
  • Patent number: 4836928
    Abstract: A body fluid is separated into respective components by passing the body fluid through a separation device. The separation device includes a lipid having lipophilic and hydrophilic groups, and a support immobilizing the lipid. The lipid is immobilized on the support such that only its hydrophilic groups contact the body fluid introduced in the separation device. Only body fluid components having a strong adherent property adhere to the hydrophilic groups of the lipid.
    Type: Grant
    Filed: April 26, 1985
    Date of Patent: June 6, 1989
    Assignee: Terumo Kabushiki Kaisha
    Inventors: Juuro Aoyagi, Yuichi Yamamoto, Toshihiro Akaike, Yasuhiro Nozaki